Market Executive Summary

The global market for Structural Heart Diseases Device was estimated to be worth US$ 15490 million in 2024 and is forecast to a readjusted size of US$ 28980 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.

Structural heart devices comprise annuloplasty rings, heart valve balloons occluders among others. These devices are used to reshape and tighten the ring around the heart, in case the heart is enlarged or has a leaky valve.

The structural heart diseases device market is driven by the growing prevalence of structural heart diseases and the increasing demand for innovative and minimally invasive treatment options. Structural heart diseases devices are medical devices used to treat abnormalities or defects in the heart"s structure, such as valve disorders or congenital heart defects. The rise in the aging population and the incidence of heart-related conditions contribute to market growth as these conditions require specialized interventions. Moreover, advancements in medical technology and the development of novel devices have improved the effectiveness and safety of structural heart disease treatments. However, the market also faces challenges, including the high cost of some devices and the need for rigorous clinical trials and regulatory approvals for new treatments. Additionally, addressing reimbursement issues and competing with conventional surgical approaches can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer cutting-edge structural heart diseases devices, collaborate with healthcare providers to expand awareness and access to treatments, and address the challenges to meet the increasing demand for effective and minimally invasive solutions for structural heart diseases.

This report aims to provide a comprehensive presentation of the global market for Structural Heart Diseases Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Structural Heart Diseases Device by region & country, by Type, and by Application.

The Structural Heart Diseases Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Structural Heart Diseases Device.

Global Structural Heart Diseases Device Companies Covered

Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical, Cardia, MicroPort, Edwards Lifesciences, Medtronic, Venus Medtech, Meril Life Sciences, Braile Biomedica

Global Structural Heart Diseases Device Market, by Region

North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Structural Heart Diseases Device Market, Segment by Type

CHD Occluder

Cardioembolic Stroke Occluder

Heart Valve

Other

Global Structural Heart Diseases Device Market, Segment by Application

Hospitals

Clinics

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Structural Heart Diseases Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Structural Heart Diseases Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Structural Heart Diseases Device in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Related Reports:

Global Structural Heart Disease Interventional Device Market Size, Share, Growth Drivers, Overall Sales and Demand Forecast To 2030

Global Structural Steel Fabrication Market Size, Share, Growth Drivers, Trends, Competitive Analysis and Forecast 2023-2030